InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Guyer Charles Greg, Directeur Exécutif. Insider active across 1 companies, notably Biomarin Pharmaceutical INC. In total, 4 reports have been published. The latest transaction was filed on 29 April 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
€14,437243 shares@ €59.41150.0001% mcap38.8% of flow
Common Stock
SEC:0001567619-22-009719:0·
011,040 shares0
Common Stock
SEC:0001567619-22-007183:0·
€11,373221 shares@ €51.4608100.0% of flow
Common Stock
SEC:0001567619-21-009154·
€11,373221 shares@ €51.46080.0001% mcap30.6% of flow
Common Stock
SEC:0001567619-21-009154:0·
4 of 4 declarations
About Guyer Charles Greg
Charles Greg Guyer is the Executive Vice President and CTO at Biomarin Pharmaceutical Inc. He is responsible for the technical direction of the company, overseeing innovation and the development of new products. Guyer is recognized for his expertise in the pharmaceutical field and his commitment to research and development.
